|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 25
Zeitschriftenartikel
Nitz, Ulrike A.; Gluz, Oleg; Kümmel, Sherko; Christgen, Matthias; Braun, Michael; Aktas, Bahriye; Lüdtke-Heckenkamp, Kerstin; Forstbauer, Helmut; Grischke, Eva-Maria; Schumacher, Claudia; Darsow, Maren; Krauss, Katja; Nuding, Benno; Thill, Marc; Potenberg, Jochem; Uleer, Christoph; Warm, Mathias; Fischer, Hans Holger; Malter, Wolfram; Hauptmann, Michael; Kates, Ronald E.; Gräser, Monika; Würstlein, Rachel; Shak, Steven; Baehner, Frederick; Kreipe, Hans H. und Harbeck, Nadia
(2022):
Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HP2-Early Breast Cancer.
In: Journal of Clinical Oncology, Bd. 40, Nr. 23: S. 2557-2567
Kolberg-Liedtke, Cornelia; Feuerhake, Friedrich; Garke, Madlen; Christgen, Matthias; Kates, Ronald; Grischke, Eva Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Kuemmel, Sherko; Wuerstlein, Rachel; Graeser, Monika; Nitz, Ulrike; Kreipe, Hans; Gluz, Oleg und Harbeck, Nadia
(2022):
Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial.
In: Breast Cancer Research, Bd. 24, Nr. 1, 58
Kreipe, Hans; Harbeck, Nadia und Christgen, Matthias
(2022):
Clinical validity and clinical utility of Ki67 in early breast cancer.
In: Therapeutic Advances in Medical Oncology, Bd. 14
Gluz, Oleg; Nitz, Ulrike; Kolberg-Liedtke, Cornelia; Prat, Aleix; Christgen, Matthias; Kuemmel, Sherko; Mohammadian, Mohammad Parsa; Gebauer, Daniel; Kates, Ronald; Pare, Laia; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Wuerstlein, Rachel; Graeser, Monika; Pelz, Enrico; Jozwiak, Katarzyna; Zu Eulenburg, Christine; Kreipe, Hans Heinrich und Harbeck, Nadia
(2022):
De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial.
In: Clinical Cancer Research, Bd. 28, Nr. 22: S. 4995-5003
de Gregorio, Amelie; Janni, Wolfgang; Friedl, Thomas W. P.; Nitz, Ulrike; Rack, Brigitte; Schneeweiss, Andreas; Kates, Ronald; Fehm, Tanja; Kreipe, Hans; Christgen, Matthias; Kuemmel, Sherko; Trapp, Elisabeth; Wuerstlein, Rachel; Haertkopf, Andreas; Clemens, Michael; Reimer, Toralf; Haeberle, Lothar; Fasching, Peter A.; Gluz, Oleg und Harbeck, Nadia
(2022):
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C.
In: British Journal of Cancer, Bd. 126, Nr. 12: S. 1715-1724
Grote, Isabel; Bartels, Stephan; Christgen, Henriette; Radner, Martin; Gronewold, Malte; Kandt, Leonie; Raap, Mieke; Lehmann, Ulrich; Gluz, Oleg; Graeser, Monika; Kuemmel, Sherko; Nitz, Ulrike; Harbeck, Nadia; Kreipe, Hans und Christgen, Matthias
(2022):
ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer.
In: Modern Pathology, Bd. 35, Nr. 12: S. 1804-1811
Nitz, Ulrike; Gluz, Oleg; Graeser, Monika; Christgen, Matthias; Kuemmel, Sherko; Grischke, Eva-Maria; Braun, Michael; Augustin, Doris; Potenberg, Jochem; Krauss, Katja; Schumacher, Claudia; Forstbauer, Helmut; Reimer, Toralf; Stefek, Andrea; Fischer, Hans Holger; Pelz, Enrico; Eulenburg, Christine zu; Kates, Ronald; Würstlein, Rachel; Kreipe, Hans Heinrich und Harbeck, Nadia
(2022):
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial.
In: Lancet Oncology, Bd. 23, Nr. 5: S. 625-635
Grote, Isabel; Bartels, Stephan; Kandt, Leonie; Bollmann, Laura; Christgen, Henriette; Gronewold, Malte; Raap, Mieke; Lehmann, Ulrich; Gluz, Oleg; Nitz, Ulrike; Kuemmel, Sherko; Zu Eulenburg, Christine; Braun, Michael; Aktas, Bahriye; Grischke, Eva-Maria; Schumacher, Claudia; Luedtke-Heckenkamp, Kerstin; Kates, Ronald; Wuerstlein, Rachel; Graeser, Monika; Harbeck, Nadia; Christgen, Matthias und Kreipe, Hans
(2021):
TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer.
In: Cancer Medicine, Bd. 10, Nr. 23: S. 8581-8594
Graeser, Monika; Schrading, Simone; Gluz, Oleg; Strobel, Kevin; Wuerstlein, Rachel; Kuemmel, Sherko; Schumacher, Claudia; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Christgen, Matthias; Adams, Jascha; Nitzsche, Henrik; Just, Marianne; Fischer, Hans Holger; Aktas, Bahriye; Potenberg, Jochem; Schumann, Raquel von; Kolberg-Liedtke, Cornelia; Harbeck, Nadia; Kuhl, Christiane K. und Nitz, Ulrike
(2021):
Early response by MR imaging and ultrasound as predictor of pathologic complete response to 12-week neoadjuvant therapy for different early breast cancer subtypes: Combined analysis from the WSG ADAPT subtrials.
In: International Journal of Cancer, Bd. 148, Nr. 10: S. 2614-2627
Graeser, Monika; Harbeck, Nadia; Gluz, Oleg; Wuerstlein, Rachel; Eulenburg, Christine zu; Schumacher, Claudia; Grischke, Eva -Maria; Forstbauer, Helmut; Dimpfl, Moritz; Braun, Michael; Christgen, Matthias; Kreipe, Hans Heinrich; Potenberg, Jochem; Schumann, Raquel von; Aktas, Bahriye; Kolberg-Liedtke, Cornelia; Kuemmel, Sherko und Nitz, Ulrike
(2021):
The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials.
In: Breast, Bd. 59: S. 58-66
Graeser, Monika; Feuerhake, Friedrich; Gluz, Oleg; Volk, Valery; Hauptmann, Michael; Jozwiak, Katarzyna; Christgen, Matthias; Kuemmel, Sherko; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Kolberg-Liedtke, Cornelia; Kates, Ronald; Wuerstlein, Rachel; Nitz, Ulrike; Kreipe, Hans Heinrich und Harbeck, Nadia
(2021):
Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial.
In: Journal for Immunotherapy of Cancer, Bd. 9, Nr. 5, e002198
Christgen, Matthias; Kandt, Leonie Donata; Antonopoulos, Wiebke; Bartels, Stephan; Bockstal, Mieke R. van; Bredt, Martin; Brito, Maria Jose; Christgen, Henriette; Colpaert, Cecile; Cserni, Balint; Cserni, Gabor; Daemmrich, Maximilian E.; Danebrock, Raihanatou; Dedeurwaerdere, Franceska; Deurzen, Carolien H. M. van; Erber, Ramona; Fathke, Christine; Feist, Henning; Fiche, Maryse; Gonzalez, Claudia Aura; Hoeve, Natalie D. ter; Kooreman, Loes; Krech, Till; Kristiansen, Glen; Kulka, Janina; Laenger, Florian; Lafos, Marcel; Lehmann, Ulrich; Martin-Martinez, Maria Dolores; Mueller, Sophie; Pelz, Enrico; Raap, Mieke; Ravarino, Alberto; Reineke-Plaass, Tanja; Schaumann, Nora; Schelfhout, Anne-Marie; Schepper, Maxim de; Schlue, Jerome; Vijver, Koen van de; Waelput, Wim; Wellmann, Axel; Graeser, Monika; Gluz, Oleg; Kuemmel, Sherko; Nitz, Ulrike; Harbeck, Nadia; Desmedt, Christine; Floris, Giuseppe; Derksen, Patrick W. B.; Diest, Paul J. van; Vincent-Salomon, Anne und Kreipe, Hans
(2021):
Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinoma.
In: Journal of Pathology Clinical Research, Bd. 8, Nr. 2: S. 191-205
Kolberg-Liedtke, Cornelia; Gluz, Oleg; Heinisch, Fred; Feuerhake, Friedrich; Kreipe, Hans; Clemens; Nuding, Benno; Malter, Wolfram; Reimer, Tora; Würstlein, Rachel; Graeser, Monika; Shak, Steve; Nitz, Ulrike; Kates, Ronald; Christgen, Matthias und Harbeck, Nadia
(2020):
Association of TILs with clinical parameters, Recurrence Score (R) results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial.
In: Breast Cancer Research, Bd. 22, Nr. 1, 47
Nitz, Ulrike; Gluz, Oleg; Kreipe, Hans H.; Christgen, Matthias; Kuemmel, Sherko; Baehner, Frederick L.; Shak, Steven; Aktas, Bahriye; Braun, Michael; Ludtke-Heckenkamp, Kerstin; Forstbauer, Helmut; Grischke, Eva-Maria; Nuding, Benno; Darsow, Maren; Schumacher, Claudia; Krauss, Katja; Malter, Wolfram; Thill, Marc; Warm, Mathias; Würstlein, Rachel; Kates, Ronald E. und Harbeck, Nadia
(2020):
The run-in phase of the prospective WSG-ADAPT HR+/HER2-trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer.
In: Therapeutic Advances in Medical Oncology, Bd. 12: S. 1-9
[PDF, 531kB]
Dowsett, Mitch; Ellis, Matthew J. 
ORCID: https://orcid.org/0000-0002-8467-8534; Dixon, J. Michael; Gluz, Oleg; Robertson, John; Kates, Ronald; Suman, Vera J.; Turnbull, Arran K.; Nitz, Ulrike; Christgen, Matthias; Kreipe, Hans; Kuemmel, Sherko; Bliss, Judith M.; Barry, Peter; Johnston, Stephen R.; Jacobs, Samuel A.; Ma, Cynthia X.; Smith, Ian E. und Harbeck, Nadia ORCID: https://orcid.org/0000-0002-9744-7372
(2020):
Evidence-based guidelines for managing patients with primary ER+ HER2- breast cancer deferred from surgery due to the COVID-19 pandemic.
In: Npj Breast Cancer, Bd. 6, Nr. 1, 21: S. 1-10
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-8467-8534; Dixon, J. Michael; Gluz, Oleg; Robertson, John; Kates, Ronald; Suman, Vera J.; Turnbull, Arran K.; Nitz, Ulrike; Christgen, Matthias; Kreipe, Hans; Kuemmel, Sherko; Bliss, Judith M.; Barry, Peter; Johnston, Stephen R.; Jacobs, Samuel A.; Ma, Cynthia X.; Smith, Ian E. und Harbeck, Nadia ORCID: https://orcid.org/0000-0002-9744-7372
(2020):
Evidence-based guidelines for managing patients with primary ER+ HER2- breast cancer deferred from surgery due to the COVID-19 pandemic.
In: Npj Breast Cancer, Bd. 6, Nr. 1, 21: S. 1-10
[PDF, 1MB]
Gluz, Oleg; Kolberg-Liedtke, Cornelia; Prat, Aleix; Christgen, Matthias; Gebauer, Daniel; Kates, Ronald; Pare, Laia; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Kuemmel, Sherko; Würstlein, Rachel; Pelz, Enrico; Nitz, Ulrike; Kreipe, Hans Heinrich und Harbeck, Nadia
(2020):
Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trial.
In: International Journal of Cancer, Bd. 146, Nr. 1: S. 262-271
Christgen, Matthias; Gluz, Oleg; Harbeck, Nadia; Kates, Ronald E.; Raap, Mieke; Christgen, Henriette; Clemens, Michael; Malter, Wolfram; Nuding, Benno; Aktas, Bahriye; Kuemmel, Sherko; Reimer, Toralf; Stefek, Andrea; Krabisch, Petra; Just, Marianne; Augustin, Doris; Graeser, Monika; Baehner, Frederick; Würstlein, Rachel; Nitz, Ulrike und Kreipe, Hans
(2020):
Differential impact of prognostic parameters in hormone receptor-positive lobular breast cancer.
In: Cancer, Bd. 126, Nr. 22: S. 4847-4858
Nitz, Ulrike; Gluz, Oleg; Clemens, Michael; Malter, Wolfram; Reimer, Toralf; Nuding, Benno; Aktas, Bahriye; Stefek, Andrea; Pollmanns, Anke; Lorenz-Salehi, Fatemeh; Uleer, Christoph; Krabisch, Petra; Kümmel, Sherko; Liedtke, Cornelia; Shak, Steven; Wuerstlein, Rachel; Christgen, Matthias; Kates, Ronald E.; Kreipe, Hans H.; Harbeck, Nadia; Ackermann, S.; Aktas, B.; Augustin, D.; Baake, G.; Baumann, K.; Berger, R.; Bettscheider, J.; Bischoff, J.; Clemens, M.; Deryal, M.; Dubbers, H.; Duchting, D.; Dunnebacke, J.; Fett, W.; Fietz, T.; Fischer, H.; Forner, M.; Forstbauer, H.; Freese, K.; Geberth, M.; Glados, M.; Gnauert, K.; Goette, O.; Gohring, U.; Goppinger, A.; Grafe, A.; Hackenberg, R.; Hackmann, J.; Hellriegel, M.; Heyl, V.; Hoestermann, C.; Hoffmann, G.; Hofmann, M.; Hucke, J.; Jackisch, C.; Jungberg, P.; Just, M.; Kahl, C.; Klare, P.; Kogel, M.; Kohls, A.; Amrawy, B. Konigs-El; Konnecke, P.; Krabisch, P.; Kraudelt, S.; Kremers, S.; Kummel, S.; Kurbacher, C.; Kusche, J.; Liedtke, B.; Liedtke, C.; Link, H.; Lorenz, R.; Salehi, F. Lorenz; Lubbe, K.; Malter, W.; Melekian, B.; Mobus, V.; Montenarh, M.; Müller, V.; Mundhenke, C.; Niederle, N.; Nitz, U.; Noesselt, T.; Oberhoff, C.; Paas, L.; Paepke, S.; Pollmanns, A.; Reichert, D.; Reimer, T.; Romann, D.; Ruhland, T.; Runde, V.; Salem, M.; Schlosser, A.; Schneider, A.; Schrader, I.; Schulz, H.; Schumacher, C.; Schwickerath, J.; Soling, U.; Stauder, H.; Stefek, A.; Steinmetz, T.; Stickeler, E.; Terhaag, J.; Thomssen, C.; Tome, O.; Uleer, C.; Warm, M.; Wachsmann, G.; Wacker, J.; Wiebringhaus, H.; Wiest, W.; Wolfgarten, M.; Nitz, U.; Christgen, H.; Kreipe, H.; Buehne, C.; Gluz, O.; Hansen, K.; Hofmann, D.; Kates, R.; Mangold, M.; Mathissen, M.; Raeth, P.; Renner, I.; Reiser, I.; Schumacher, J.; Staedele, M. und Walter-Kirst, R.
(2019):
West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Breast Cancer.
In: Journal of Clinical Oncology, Bd. 37, Nr. 10
Christgen, Matthias; Bartels, Stephan; Radner, Martin; Raap, Mieke; Rieger, Luisa; Christgen, Henriette; Gluz, Oleg; Nitz, Ulrike; Harbeck, Nadia; Lehmann, Ulrich und Kreipe, Hans
(2019):
ERBB2 mutation frequency in lobular breast cancer with pleomorphic histology or high-risk characteristics by molecular expression profiling.
In: Genes Chromosomes & Cancer, Bd. 58, Nr. 3: S. 175-185
Gluz, Oleg; Nitz, Ulrike; Liedtke, Cornelia; Christgen, Matthias; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Bangemann, Nikola; Lindner, Christoph; Kuemmel, Sherko; Clemens, Michael; Potenberg, Jochem; Staib, Peter; Kohls, Andreas; Schumann, Raquel von und Harbeck, Nadia
(2018):
Comparison of Neoadjuvant Nab-Paclitaxe plus Carboplatin vs Nab-Paclitaxe plus Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results.
In: Jnci-Journal of the National Cancer Institute, Bd. 110, Nr. 6, djx258: S. 628-637
Raap, Mieke; Gronewold, Malte; Christgen, Henriette; Glage, Silke; Bentires-Alj, Mohammad; Koren, Shany; Derksen, Patrick W.; Bölens, Mirjam; Jonkers, Jos; Lehmann, Ulrich; Feuerhake, Friedrich; Kühnle, Elna; Gluz, Oleg; Kates, Ronald; Nitz, Ulrike; Harbeck, Nadia; Kreipe, Hans H. und Christgen, Matthias
(2018):
Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2 beta.
In: Laboratory Investigation, Bd. 98, Nr. 1: S. 117-129
Nitz, Ulrike; Gluz, Oleg; Christgen, Matthias; Kates, Ronald E.; Clemens, Michael; Malter, Wolfram; Nuding, Benno; Aktas, Bahriye; Kümmel, Sherko; Reimer, Toralf; Stefek, Andrea; Lorenz-Salehi, Fatemeh; Krabisch, Petra; Just, Marianne; Augustin, Doris; Liedtke, Cornelia; Chao, Calvin; Shak, Steven; Würstlein, Rachel; Kreipe, Hans H. und Harbeck, Nadia
(2017):
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial.
In: Breast Cancer Research and Treatment, Bd. 165, Nr. 3: S. 573-583
Harbeck, Nadia; Gluz, Oleg; Christgen, Matthias; Kates, Ronald Ernest; Braun, Michael; Küemmel, Sherko; Schumacher, Claudia; Potenberg, Jochem; Krämer, Stefan; Kleine-Tebbe, Anke; Augustin, Doris; Aktas, Bahriye; Forstbauer, Helmut; Tio, Joke; Schumann, Raquel von; Liedtke, Cornelia; Grischke, Eva-Maria; Schumacher, Johannes; Würstlein, Rachel; Kreipe, Hans Heinrich und Nitz, Ulrike Anneliese
(2017):
De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early BC HER2-and Hormone Receptor-Positive Phase II Randomized Trial-Efficacy, Safety, and Predictive Markers for 12 Weeks of Neoadjuvant Trastuzumab Emtansine With or Without Endocrine Therapy (ET) Versus Trastuzumab Plus ET.
In: Journal of Clinical Oncology, Bd. 35, Nr. 26: S. 3046-3056
Gluz, Oleg; Nitz, Ulrike A.; Christgen, Matthias; Kates, Ronald E.; Shak, Steven; Clemens, Michael; Kraemer, Stefan; Aktas, Bahriye; Kuemmel, Sherko; Reimer, Toralf; Kusche, Manfred; Heyl, Volker; Lorenz-Salehi, Fatemeh; Just, Marianne; Hofmann, Daniel; Degenhardt, Tom; Liedtke, Cornelia; Svedman, Christer; Wuerstlein, Rachel; Kreipe, Hans H. und Harbeck, Nadia
(2016):
West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment.
In: Journal of Clinical Oncology, Bd. 34, Nr. 20:
2341-U66
Christgen, Matthias; Steinemann, Doris; Kühnle, Elna; Länger, Florian; Gluz, Oleg; Harbeck, Nadia und Kreipe, Hans
(2016):
Lobular breast cancer: Clinical, molecular and morphological characteristics.
In: Pathology Research and Practice, Bd. 212, Nr. 7: S. 583-597